U.S. Pharmaceuticals: The Future of Genetic Medicine
Thoughts on the Market - En podkast av Morgan Stanley
Kategorier:
As new gene therapies are researched, developed and begin clinical trials, what hurdles must genetic medicine overcome before these therapies are commonly available? Head of U.S. Pharmaceuticals Terence Flynn and Head of U.S. Biotech Matthew Harrison discuss.
